We measured isotype-specific human antibodies directed against Campylobacterjejuni native flagellin and a synthetic peptide derived from the N-terminal amino acid sequence of the protein by using a microdilution enzyme-linked immunosorbent assay (ELISA). Serum samples from patients with gastrointestinal infection caused by C. jejuni (n = 20) and control samples (number from normal subjects = 20; number from patients with diarrhea other than campylobacter = 20) were tested in this assay. Serum specimens from patients with campylobacter infection showed statistically significant higher isotype-specific antiflagellin antibody titers than control samples did. Detection of immunoglobulin G (IgG) antibodies was less specific (70%) than detection of either IgA or IgM antibodies in infected patients (95 %). The sensitivity of testing for any of the isotypes ranged from 64 to 100% in acute-phase serum specimens and 85 to 95% in convalescent-phase serum specimens. An ELISA with an N-terminal synthetic peptide derived from the flagellin protein as antigen was not sensitive (60%) for detecting campylobacter infection but was very specific (97.5%). In conclusion, detection of serum
Several studies have suggested that the flagellum of Campylobacter jejuni is an important virulence determinant for establishment of campylobacter infections in humans (7, 8) . Antibodies to flagellin, the major protein subunit of the flagellar filament, can be detected after natural human infection (9, 14) . Several studies have shown that there is a strong humoral response during infection, as measured by immunoassays in which a variety of campylobacter cellular antigens are used (1, 3, 4, 11) . The diagnostic value of immunoassays in which specific flagellar antigen is used has not been studied, although some of the antigenic components used in these studies have also included flagellin. In order to assess the diagnostic value of an enzyme-linked immunosorbent assay (ELISA) for detecting campylobacter infection in humans, we used purified flagellin protein as antigen and measured the isotype-specific response to this protein. In addition, we used a synthetic peptide derived from the N-terminal amino acid sequence of flagellin (5, 10) obtained, additional control serum specimens were obtained from 20 healthy second-year University of Pennsylvania medical students (normal group), since this group would be the group most similar to patients being seen in our Student Health Clinic for diarrheal illness, and from 20 patients with diarrheal illness not caused by C. jejuni (diarrhea group).
Preparation of antigens. Flagellin from strain IN1 (10) was purified by methods previously described (10) and was used as antigen for ELISA. Synthetic peptides were prepared by solid-phase peptide synthesis with a peptide synthesizer (Applied Biosystems). Peptides were further modified by the addition of a single C-terminal cysteine residue in order that the peptide could be linked to bovine serum albumin (BSA) for ELISA studies. Three different-length peptides were used, as shown in Fig. 1 . Cysteine-modified synthetic peptide was coupled to BSA by using the heterobifunctional reagent SPDP [N-succinmidyl-3(2-pyridylthio) proprionate] (SPDP, 20 mM; Pierce Chemical Co., Rockford, 111.) by the method of Carlsson et al. (2) . After coupling of synthetic peptide to BSA, free peptide was removed from conjugated peptide by dialysis against phosphate-buffered saline (PBS). Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis (without 2-mercaptoethanol) with 10% acrylamide gels was used to verify conjugation of peptide with BSA. On the basis of the molecular weight of the conjugated peptide, we estimate that peptide linked to BSA in a 1:1 ratio.
Measurement of antibodies against native flagellin and synthetic peptide. The ELISA for detecting isotype-specific antibody was performed with minor modifications by the procedure described by Voller and Bidwell (13) . Microdilution plates (Immunlon; Dynatech Laboratories, Inc., Alexandria, Va.) were coated with 150 pl of native flagellin (10 ,ug/ml) or conjugated peptide (10 ,ug/ml of protein) diluted in carbonate coating buffer, pH 9.6, and incubated for a minimum of overnight at 4°C. Wells were washed three times with PBS-0.5% Tween 20, pH 7.4. Wells were then blocked with 1% BSA-PBS, pH 7.4, for 1 h at 37°C. Dilutions of human serum specimens prepared in PBS were added in duplicate to appropriate wells and incubated at 4°C overnight. Wells were washed three times with PBS-0.5% Tween 20 and 150 ,ug of goat anti-human isotype-specific immunoglobulin-alkaline phosphatase conjugate (1:1,000 dilution in PBS-0.5% Tween 20; Sigma Chemical Co., St. Louis, Mo.) for 1 h at 37°C. After wells were washed three times with PBS-0.5% Tween 20, substrate (p-nitrophenylphosphate, 1 mg/ml) was added, and the specimens were incubated for 30 min in the dark at room temperature. A total of 50 tl of 3 M NaOH was added to each well to stop the reaction, and the optical density of each well was determined by using an ELISA reader at 405 nm.
The anti-native flagellin antibody titer was determined by taking the highest dilution of serum that gave an optical density value of 0.200. In order to detect antibodies directed against the synthetic peptide, we compared the optical density of serum incubated with BSA-peptide conjugate with the optical density of serum incubated with BSA alone. Serum specimens that exhibited a ratio of .3.0 (i.e., three times background) were.considered positive and indicated the presence of antibody to the peptide.
Competitive inhibition study. Increasing amounts of unconjugated, free 1-C peptide were preincubated with dilutions of human serum (patient 2); they were then serum assayed in the standard ELISA as described above.
Statistical analysis. Comparison of antibody titers among the different patient groups was performed by using the Mann-Whitney U Test (12) . Gly-Phe-Arc-119-Aon-Thr-Aon-Vol-Alo-Alo-Leu-Aen-Ale-Lys-Ale-Aon-Alo-Asp.-Leu-Ann-(C») Table 3 shows the reactivities of sera from campylobacter patients who were positive in the antipeptide antibody ELISA, along with the control group values. IgG antipeptide antibody was detected in 40% of patients with campylobacter infection versus 20% for IgA and 30% for IgM. Several patients exhibited reactivity patterns such that antibody was not detected by using the shorter-length peptides (1-A and 1-B) but reactivity was observed with the full-length peptide (1-C). Thus, either an epitope is present near the first five amino acid residues or the addition of these amino acids altered the secondary structure of the peptide such that other regions were now antigenic.
We performed a competitive inhibition experiment with serum from one patient (patient 2) by using free 1-C peptide to demonstrate specificity of the reaction. Figure 2 shows the results of this study. The antibody reactivity of IgG against the peptide in the ELISA could be specifically inhibited by preincubating the serum specimens with as little as 0.01 ng of peptide. Control incubations with a nonrelated peptide did not show any decrease in ELISA optical density values (data not shown).
DISCUSSION
Numerous studies measuring antibodies to campylobacter antigens have been performed (1, 3, 4, 6, 11 (4) found that in five patients with numerous followup serum specimens, fourfold or greater increases or deceases in antibody titer were observed within 2 to 5 days after a previous serum specimen had been collected.
In contrast to measuring antibodies to native flagellin, we found much higher specificity for measuring isotype-specific antibodies against a synthetic peptide derived from the N-terminal region of the native protein. Only 1 (from the diarrhea group) of 40 control serum specimens showed significant reactivity against this peptide when a ratio of c3.0 was used to indicate positivity. That some control serum specimens exhibited ratios between one and three suggests that these serum specimens contain antibodies that cross-react with the peptide sequence, but at a much lower level. Such cross-reacting antibodies may be from prior exposure to campylobacter or to bacterial flagellins with homology to C. jejuni (5, 10) . Previous studies have shown a e e~~~ẽ that the N-terminal region of flagellin is conserved among serologically distinct strains of C. jejuni (5, 10) ; however, the immune response does not appear to be directed primarily against this region.
Our studies suggest that defined synthetic antigens with broader reactivity might make useful serologic tools for the diagnosis of campylobacter infections. Further studies are needed, however, to define specific regions of the flagellin protein that can be used in such assays.
